Literature DB >> 11476228

Determination of beta-2 microglobulin levels in plasma using a high-throughput mass spectrometric immunoassay system.

E E Niederkofler1, K A Tubbs, K Gruber, D Nedelkov, U A Kiernan, P Williams, R W Nelson.   

Abstract

A high-throughput mass spectrometric immunoassay (MSIA) system for the analysis of proteins directly from biological fluids is reported. A 96-well-format robotic workstation equipped with antibody-derivatized affinity pipet tips was used for the parallel extraction of specific proteins from samples and subsequent deposition onto 96-well arrayed matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOFMS) targets. Interferences from nonspecifically bound proteins were minimized through choice of appropriate affinity pipet tip derivatization chemistries. Sample preparation for MALDI-TOFMS was enhanced through the use of hydrophobic/hydrophilic contrasting targets, which also presented functionalities found to promote matrix/analyte crystal growth. Automated mass spectrometry was used in the unattended acquisition of data, resulting in an analysis rate of approximately 100 samples/h (biological fluid-->data). The quantitative MSIA of beta2m levels present in human plasma samples is given as illustration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11476228     DOI: 10.1021/ac010143j

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  20 in total

1.  Quantitative measurement of full-length and C-terminal proteolyzed RBP4 in serum of normal and insulin-resistant humans using a novel mass spectrometry immunoassay.

Authors:  Qin Yang; Iratxe Eskurza; Urban A Kiernan; David A Phillips; Matthias Blüher; Timothy E Graham; Barbara B Kahn
Journal:  Endocrinology       Date:  2012-01-17       Impact factor: 4.736

Review 2.  Mass spectrometric immunoassay revisited.

Authors:  Randall W Nelson; Chad R Borges
Journal:  J Am Soc Mass Spectrom       Date:  2011-03-08       Impact factor: 3.109

3.  Population studies of intact vitamin D binding protein by affinity capture ESI-TOF-MS.

Authors:  Chad R Borges; Jason W Jarvis; Paul E Oran; Stephen P Rogers; Randall W Nelson
Journal:  J Biomol Tech       Date:  2008-07

Review 4.  Mass-spectrometry-based clinical proteomics--a review and prospective.

Authors:  Carol E Parker; Terry W Pearson; N Leigh Anderson; Christoph H Borchers
Journal:  Analyst       Date:  2010-06-02       Impact factor: 4.616

5.  Sensitive electrochemical immunosensor for matrix metalloproteinase-3 based on single-wall carbon nanotubes.

Authors:  Bernard S Munge; Jacqueline Fisher; Lines N Millord; Colleen E Krause; Richard S Dowd; James F Rusling
Journal:  Analyst       Date:  2010-03-31       Impact factor: 4.616

6.  Sensitive immunosensor for cancer biomarker based on dual signal amplification strategy of graphene sheets and multienzyme functionalized carbon nanospheres.

Authors:  Dan Du; Zhexiang Zou; Yongsoon Shin; Jun Wang; Hong Wu; Mark H Engelhard; Jun Liu; Ilhan A Aksay; Yuehe Lin
Journal:  Anal Chem       Date:  2010-04-01       Impact factor: 6.986

7.  A Low-Cost Nanomaterial-based Electrochemical Immunosensor on Paper for High-Sensitivity Early Detection of Pancreatic Cancer.

Authors:  K Sudhakara Prasad; Xiyue Cao; Ning Gao; Qijie Jin; Sharma T Sanjay; Gilberto Henao-Pabon; XiuJun Li
Journal:  Sens Actuators B Chem       Date:  2019-12-02       Impact factor: 7.460

8.  Possibilities and pitfalls in quantifying the extent of cysteine sulfenic acid modification of specific proteins within complex biofluids.

Authors:  Douglas S Rehder; Chad R Borges
Journal:  BMC Biochem       Date:  2010-07-01       Impact factor: 4.059

9.  An immunoaffinity tandem mass spectrometry (iMALDI) assay for detection of Francisella tularensis.

Authors:  Jian Jiang; Carol E Parker; James R Fuller; Thomas H Kawula; Christoph H Borchers
Journal:  Anal Chim Acta       Date:  2007-10-23       Impact factor: 6.558

10.  Glycosylation status of vitamin D binding protein in cancer patients.

Authors:  Douglas S Rehder; Randall W Nelson; Chad R Borges
Journal:  Protein Sci       Date:  2009-10       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.